The PR this morning is what good businesses do. They gave an update in March regarding the certification process at Sawston and today they showed that they’re on target with the timeline they provided. Anyone who’s been critical of management’s transparency can see that when they have solid info they’ll release it. This is a big improvement.
If they stay on the timeline regarding Sawston, as they’ve shown they can do, one can look into the continued timeline they provide today and see it may line up perfectly with UK approval of DCVax-L. If they start working now on getting the application for FlaskWorks (they say they have a machine there now) by running concurrent vaccines on the FlaskWorks machine they could have certification by the time of UK approval.
Now, you’re going to start hearing a lot today from the usual suspects LC, Ex, etc. that will try to make people think NWBO’s only talking about Sawston to distract us retail investors because what they’re really doing is getting Sawston up and running to be able to do other company’s Cellular Products because the trial has failed. Please resist this nonsense.
The fact is this; if you watch Bloomberg or CNBC, etc. you’ll see they have analysts on all the time making forward looking predictions on the market for the near and distant future and on specific sectors and specific stocks. This morning on Bloomberg they had an analyst who discussed commodities in the coming months and in particular Iron and Copper. His position was Iron would drop because of policies in the Chinese economy and Copper would rise because of a global movement in policy to Green Energy. With the PR today I look beyond TLD, because TLD will come and it will be spectacular. I look at what they’re able to say with clarity right now; Sawston is coming on line with a timeline that an astute investor can look at (while keeping TLD in mind) and make a reasonable, rational, and informed analysis that NWBO believe they have a product that will be approved across all RAs.
